FdaApplication
ANDA 205095
Identifiers
- fda_app_no: ANDA205095
Properties
| Property | Value |
|---|---|
| applicant_name | SCIEGEN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2016-05-16 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RUFINAMIDE | RUFINAMIDE | 200MG | TABLET;ORAL |
| RUFINAMIDE | RUFINAMIDE | 400MG | TABLET;ORAL |
2 products